The clinical research landscape is changing and clinical trials are evolving to find new, faster and more efficient ways to bring new treatments to patients.
The NIHR has been supporting the delivery of novel, complex and innovative clinical trials over the last decade. Find out how we can support you to plan, set up and deliver your trial or study to time and target in the UK.
Complex clinical trial designs (methodologies) and innovative approaches to recruitment and delivery have the potential to improve the speed and efficiency of clinical trials, shorten drug development timelines and, ultimately, bring new treatments to patients faster. Developments in science and technology also mean that innovative clinical trials are needed to assess new medicines in different (often smaller, more specific) patient populations.
The NIHR is responding to this evolution and on this page you can discover how we are supporting the next generation of clinical trials.
Through case study content you will find out how we are advocating the adoption of the adaptive trial model, helping to realise the value of registry-facilitated research, and promoting the benefits of the platform approach, to name just a few.
The phrase ‘complex and innovative trial design’ includes, but extends further than the trial methodology or design. The complexity may also exist in the set-up, recruitment, delivery or the statistical analysis and mathematics which underpin the trial. The term should be used in its broadest sense, and not be limited to specific trial designs.
Any trial design that differs from the standard randomised controlled trial (RCT) design and delivers results more efficiently, reduces the study timeline, and maximises the knowledge gained could be described as novel or innovative.
Common examples of methodologies that are considered complex and/or innovative include:
The following case studies illustrate how the NIHR has been supporting some of these approaches:
When we talk about ‘innovative delivery’ we are focusing on the set-up and the delivery of the trial, as opposed to the design. The design may be simple or standard, but the way it is delivered may be more streamlined, efficient, quicker or more patient-friendly than what has been done before. The term should be used in its broadest sense for all approaches that present an innovative solution to trial delivery. For example, this includes research that is conducted using:
The list is not exhaustive and other approaches, such as patient-led trials, also fall into this category.
The following case studies illustrate how the NIHR has been supporting some of these approaches.
The NIHR is evolving the UK’s research infrastructure to support innovative clinical trials. One of our priorities is to ensure that the NHS workforce has the knowledge and skills required to deliver the next generation of clinical trials.
We have developed an eLearning resource which is freely available to all NHS and NIHR staff (and other organisations on request) via NIHR Learn. If you are not NIHR or NHS and you would like to access this eLearning resource please get in touch using the contact form in the Quick Links section above.
Below you will find a video which provides a taster of this learning resource. We have also created a podcast series which can be accessed via our case study library.
STAMPEDE, FOCUS4 and Lung Matrix are milestones in the history of innovative trial designs in the UK. Could these flagship trials have paved the way for our #COVID19 successes?
